Larson Financial Group’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.8K Buy
1,293
+359
+38% +$8.3K ﹤0.01% 1746
2026
Q1
$22.4K Buy
934
+376
+67% +$9.19K ﹤0.01% 1779
2025
Q4
$12.6K Buy
558
+393
+238% +$8.55K ﹤0.01% 1981
2025
Q3
$3.32K Buy
165
+81
+96% +$1.36K ﹤0.01% 2509
2025
Q2
$1.2K Sell
84
-181
-68% -$2.12K ﹤0.01% 2587
2025
Q1
$2.78K Buy
265
+124
+88% +$1.4K ﹤0.01% 2064
2024
Q4
$1.71K Buy
+141
New +$1.84K ﹤0.01% 1919
2022
Q1
Sell
-83
Closed -$2K 1077
2021
Q4
$2K Buy
+83
New +$2.58K ﹤0.01% 942

Other funds holding ELAN

Larson Financial Group's ELAN Position: Q2 2026 in Review

Larson Financial Group increased its Elanco Animal Health (ELAN) stake by 38% in Q2 2026, buying an estimated $8.3K and bringing the position to 1,293 shares worth $31.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1746.

Larson Financial Group first reported a position in ELAN in Q4 2021 and has held it in 8 quarters since. 520 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Larson Financial Group held 1,293 shares of Elanco Animal Health worth $31.8K as of Q2 2026.
  • Larson Financial Group bought 359 Elanco Animal Health shares in Q2 2026, an estimated $8.3K.
  • Elanco Animal Health made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #1746 holding.
  • Larson Financial Group first reported a position in Elanco Animal Health in Q4 2021 and has held it in 8 quarters since.
  • 520 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.